Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic.
Charpentier, Charlotte
Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic. [electronic resource] - AIDS research and human retroviruses Jan 2012 - 87-94 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1931-8405
10.1089/aid.2011.0035 doi
Adolescent
Anti-HIV Agents--therapeutic use
Central African Republic--epidemiology
Child
Child, Preschool
Cross-Sectional Studies
Drug Resistance, Viral--drug effects
Female
Follow-Up Studies
HIV Infections--drug therapy
HIV-1--genetics
Humans
Male
Mutation--drug effects
RNA, Viral--blood
Treatment Outcome
Viral Load--drug effects
Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic. [electronic resource] - AIDS research and human retroviruses Jan 2012 - 87-94 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1931-8405
10.1089/aid.2011.0035 doi
Adolescent
Anti-HIV Agents--therapeutic use
Central African Republic--epidemiology
Child
Child, Preschool
Cross-Sectional Studies
Drug Resistance, Viral--drug effects
Female
Follow-Up Studies
HIV Infections--drug therapy
HIV-1--genetics
Humans
Male
Mutation--drug effects
RNA, Viral--blood
Treatment Outcome
Viral Load--drug effects